Old website version
Рус Eng
  • About center
    • General Information
    • History
    • Areas of Research
    • Departments and laboratories
    • Management of the Center
    • Microbiology Council
    • Dissertations Committees
    • Ethics Committee
    • Russian Ministry of Health and WHO Centers
    • Institute of Virology
    • «Medgamal» Branch
    • Electronic Library
  • Research
    • Vaccine against COVID-19
    • Ebola
    • MERS
    • Influenza vaccine
    • Ftortiazinon
    • Pertussis Vaccine
  • Education
    • Department of Infectious Diseases and Virology
    • Postgraduate Studies
  • Newsroom
    • Main news
    • News from the Academic Council
    • News from Dissertation Committees
    • News from the Microbiology Academic Committee
    • News from departments and laboratories
    • Educational news
    • Professional scientific potential
    • EBOLA vaccine
    • Media about us
    • News of the «Medgamal» Branch
  • Contacts
  • About center
    • General Information
    • History
    • Areas of Research
    • Departments and laboratories
    • Management of the Center
    • Microbiology Council
    • Dissertations Committees
    • Ethics Committee
    • Russian Ministry of Health and WHO Centers
    • Institute of Virology
    • «Medgamal» Branch
    • Electronic Library
  • Research
    • Vaccine against COVID-19
    • Ebola
    • MERS
    • Influenza vaccine
    • Ftortiazinon
    • Pertussis Vaccine
  • Education
    • Department of Infectious Diseases and Virology
    • Postgraduate Studies
  • Newsroom
    • Main news
    • News from the Academic Council
    • News from Dissertation Committees
    • News from the Microbiology Academic Committee
    • News from departments and laboratories
    • Educational news
    • Professional scientific potential
    • EBOLA vaccine
    • Media about us
    • News of the «Medgamal» Branch
  • Contacts
  • Vaccine against COVID-19
  • Ebola
  • MERS
  • Influenza vaccine
  • Ftortiazinon
  • Pertussis Vaccine

MERS

Gamaleya MERS vaccine

Clinical trial:

Study of Safety and Immunogenicity of BVRS-GamVac

Study of Safety and Immunogenicity of BVRS-GamVac-Combi

Scientific publications:

Ozharovskaia TA, Zubkova OV, Dolzhikova IV, et al. Immunogenicity of Different Forms of Middle East Respiratory Syndrome S Glycoprotein. Acta Naturae. 2019;11(1):38-47.

CONTACTS
18 Gamaleya St., Moscow, Russia,
123098
Tel.: +7 (499) 193-30-01
Fax: +7 (499) 193-61-83
E-mail: info@gamaleya.org
About center
General Information History Areas of Research Departments and laboratories Management of the Center Microbiology Council Dissertations Committees Ethics Committee Russian Ministry of Health and WHO Centers Institute of Virology «Medgamal» Branch Electronic Library
Research
Vaccine against COVID-19 Ebola MERS Influenza vaccine Ftortiazinon Pertussis Vaccine
Education
Department of Infectious Diseases and Virology Postgraduate Studies
Newsroom
Main news News from the Academic Council News from Dissertation Committees News from the Microbiology Academic Committee News from departments and laboratories Educational news Professional scientific potential EBOLA vaccine Media about us News of the «Medgamal» Branch
CONTACTS
18 Gamaleya St., Moscow, Russia, 123098
Tel.: +7 (499) 193-30-01
Fax: +7 (499) 193-61-83
E-mail: info@gamaleya.org
Contacts page
All rights reserved. 2023 Old website version